TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
TAF13 |
TAF13, TAF2K, TAFII18: Transcription initiation factor TFIID subunit 13 |
4.09 |
Evidence |
O
|
DMC1 |
DMC1, DMC1H, LIM15: Meiotic recombination protein DMC1/LIM15 homolog |
RUVBL2 |
RUVBL2, TIP48, CGI-46, TIP49B: RuvB-like 2 |
4.09 |
Evidence |
O
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
GRAP |
GRAP: GRB2-related adapter protein |
4.09 |
Evidence |
|
HIST1H2BO |
HIST1H2BO, H2BFH, H2BFN: Histone H2B type 1-O |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
4.09 |
Evidence |
|
CRKL |
CRKL: Crk-like protein |
CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
4.085 |
Evidence |
|
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
HTR2B |
HTR2B: 5-hydroxytryptamine receptor 2B |
4.085 |
Evidence |
|
BMP6 |
BMP6, VGR: Bone morphogenetic protein 6 precursor |
BMP7 |
BMP7, OP1: Bone morphogenetic protein 7 precursor |
4.085 |
Evidence |
|
SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
4.085 |
Evidence |
|
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
EPHB6 |
EPHB6: Ephrin type-B receptor 6 precursor |
4.085 |
Evidence |
|
INHBB |
INHBB: Inhibin beta B chain precursor |
BMP6 |
BMP6, VGR: Bone morphogenetic protein 6 precursor |
4.085 |
Evidence |
|
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
4.085 |
Evidence |
|
EFNA2 |
EFNA2, EPLG6, LERK6: Ephrin-A2 precursor |
THBS3 |
THBS3, TSP3: Thrombospondin-3 precursor |
4.085 |
Evidence |
|
HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
TAF13 |
TAF13, TAF2K, TAFII18: Transcription initiation factor TFIID subunit 13 |
4.085 |
Evidence |
|
BMP2 |
BMP2, BMP2A: Bone morphogenetic protein 2 precursor |
BMP7 |
BMP7, OP1: Bone morphogenetic protein 7 precursor |
4.085 |
Evidence |
|
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
ADRA2A |
IPI00031712 |
4.085 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
4.085 |
Evidence |
|
FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
4.085 |
Evidence |
|
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
EPHB6 |
EPHB6: Ephrin type-B receptor 6 precursor |
4.085 |
Evidence |
|
NRAS |
NRAS, HRAS1: GTPase NRas precursor |
MTMR3 |
MTMR3, KIAA0371, ZFYVE10: Myotubularin-related protein 3 |
4.085 |
Evidence |
|
FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
HHEX |
HHEX, HEX, PRH, PRHX: Homeobox protein PRH |
4.085 |
Evidence |
|
SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
4.085 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
STX1A |
STX1A, STX1: Syntaxin-1A |
4.08 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
4.08 |
Evidence |
|
CD36 |
CD36, GP3B, GP4: Platelet glycoprotein 4 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
4.08 |
Evidence |
|
NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
PSD |
TYL: TYL protein |
4.08 |
Evidence |
|